MONDAY DEADLINE: Berger Montague Advises Cepton, Inc. (NASDAQ: CPTN) Investors to Inquire About a Securities Fraud Class Action by December 8, 2025

MONDAY DEADLINE: Berger Montague Advises Cepton, Inc. (NASDAQ: CPTN) Investors to Inquire About a Securities Fraud Class Action by December 8, 2025 GlobeNewswire December 05, 2025 PHILADELPHIA, Dec. 05, 2025 (GLOBE NEWSWIRE) — National plaintiffs' law firm Berger Montague PC announces a class action lawsuit against Cepton, Inc. (NASDAQ: CPTN) (“Cepton” or the “Company”) on […]

Aerospace Materials Market Size, Share & Trends Analysis Report 2026- 2035

Aerospace Materials Market Size, Share & Trends Analysis Report 2026- 2035 According to Towards Chemical and Materials Consulting, the global aerospace materials market size was estimated at USD 47.86 billion in 2025 and is projected to reach USD 112.78 billion by 2035, growing at a CAGR of 37.11% from 2026 to 2035. GlobeNewswire December 05,

Statement – G7 Labour and Employment Ministers’ Communiqué

— We, the G7 Labour and Employment Ministers, met virtually on December 3, 2025, together with Heads of the International Labour Organization (ILO), the Organisation for Economic Cooperation and Development (OECD), the Business 7 (B7), and the Labour 7 (L7). — We reaffirmed our shared commitment to advancing financial, economic and social policy, address issues

Law Firms Announce Application for an Award of Attorneys’ Fees and Expenses in connection with Lawsuit Pending in the Delaware Court of Chancery captioned Assad v. Hess Corporation, et al., Case No. 2024-0468-NAC (Del. Ch.)

NEW YORK and DELAWARE, Dec. 05, 2025 (GLOBE NEWSWIRE) — The law firms of Acocelli Law, PLLC, and Long Law, LLC (collectively, the “Firms”), announce their intention to file an application for an award of attorneys' fees and reimbursement of expenses (the “Fee and Expense Application”) in a lawsuit pending in the Delaware Court of

Embassy Bancorp, Inc. Announces Promotion of Jeffrey Skumin to Chief Financial Officer

(Other OTC:EMYB),(OTC US:EMYB), BETHLEHEM, Pa., Dec. 05, 2025 (GLOBE NEWSWIRE) — Embassy Bancorp, Inc. (OTCQX: EMYB) (the “Company” or “Embassy”) is pleased to announce the promotion of Jeffrey Skumin to Chief Financial Officer (CFO) of the Company and its subsidiary bank, Embassy Bank for the Lehigh Valley, effective December 31, 2025. In his new role,

Embassy Bancorp, Inc. Announces Promotion of Jeffrey Skumin to Chief Financial Officer

Embassy Bancorp, Inc. Announces Promotion of Jeffrey Skumin to Chief Financial Officer GlobeNewswire December 05, 2025 BETHLEHEM, Pa., Dec. 05, 2025 (GLOBE NEWSWIRE) — Embassy Bancorp, Inc. (OTCQX: EMYB) (the “Company” or “Embassy”) is pleased to announce the promotion of Jeffrey Skumin to Chief Financial Officer (CFO) of the Company and its subsidiary bank, Embassy

Law Firms Announce Application for an Award of Attorneys’ Fees and Expenses in connection with Lawsuit Pending in the Delaware Court of Chancery captioned Assad v. Hess Corporation, et al., Case No. 2024-0468-NAC (Del. Ch.)

Law Firms Announce Application for an Award of Attorneys' Fees and Expenses in connection with Lawsuit Pending in the Delaware Court of Chancery captioned Assad v. Hess Corporation, et al., Case No. 2024-0468-NAC (Del. Ch.) GlobeNewswire December 05, 2025 NEW YORK and DELAWARE, Dec. 05, 2025 (GLOBE NEWSWIRE) — The law firms of Acocelli Law,

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Caledonia Mining Corporation Plc – CMCL

NEW YORK, NY / ACCESS Newswire / December 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Caledonia Mining Corporation Plc ("Caledonia Mining" or the "Company") (NYSE:CMCL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Caledonia Mining and certain of its

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prelude Therapeutics Incorporated – PRLD

NEW YORK CITY, NY / ACCESS Newswire / December 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Prelude Therapeutics Incorporated ("Prelude" or the "Company") (NASDAQ:PRLD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Prelude and certain of its officers and/or

Scroll to Top